EFFECT OF PERINATAL FACTORS ON THE ADIPOCYTOKINE’S LEVEL IN OBESE PATIENTS

Authors

  • Khyzhnyak O. O. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine https://orcid.org/0000-0002-4541-5248
  • Sulima T. N. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Cherevko I. G. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Manskaya K. G. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Alekseeva I. I. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine

DOI:

https://doi.org/10.21856/j-PEP.2012.4.01

Keywords:

obesity, adipocytokines, adiponectine, leptin, insulin, insulin resistance

Abstract

The adiponectine, leptin and insulin levels in both sex obese patients 11-43 years old were under investigation. Such factor as body mass at birth was considered the main cause of adipocytokine’s alteration and insulin resistance development. It was proved that individuals born with low (< 2499 gr) and high (> 4000 gr) body mass are at risk to have decreased level of adiponectine and increased level of leptin. In turn above mentioned alteration of adipocytokines level may lead to insulin resistance development.

References

Ravelli, G. P. Obesity in young men after famine exposure in utero and early infancy [Text] / G. P. Ravelli, Z. A. Stein, M.W. Susser // N. Engl. J. Med. — 1976. — Vol. 295. — P. 349–353.

Developmental programming of the metabolic syndrome by maternal nutritional imbalance: how strong is the evidence from experimental models in mammals? [Text] / J. A. Armitage, I. Y. Khan, P. D. Taylor [et al.] // J. Physiol. — 2004. —Vol. 561. — P. 355–377.

Being big or growing fast: systematic review of size and growth in infancy and later obesity [Text] / J. Baird, D. Fisher, P. Lucas [et al.] // BMJ. — 2005. — Vol. 331. — P. 929–950.

Maternal nutritional programming of fetal adipose tissue development: differential effects on messenger ribonucleic acid abundance for uncoupling proteins and peroxisome proliferator-activated and prolactin receptors [Text] / J. Bispham, D.S. Gardner, M. G. Gnanalingham [et al.] // Endocrinology. — 2005. — Vol. 146. — P. 3943–3949.

Weight in infancy and death from ischemic heart disease [Text] / D. J. Baker, P. D. Winter, C. Osmond [et al.] // Lancet. — 1989. — № 2. — P. 577–580.

Barker, D. J. Fetal origins of coronary heart disease [Text] / D. J. Barker // BMJ. — 1995. — Vol. 311. — P. 171–174.

Taylor, P. D. Developmental programming of obesity in mammals [Text] / P. D. Taylor, L. Poston // Experimental Physiology. — 2007. — Vol. 92, № 3. — P. 287–298.

l’Allemand-Jander, D. Clinical diagnosis of metabolic and cardiovascular risks in overweight children: early development of chronic diseases in the obese child [Text] / D. l’Allemand-Jander // Int. J. Obes. — 2010. — Suppl. 2. — S 32–36.

Obesity at the age of 50 y in men and women expose to famine prenatally [Text] / G. P. . Ravelli, J. H. van Der Meulen, C. Osmond [et al.] // Amer. J. Clin. Nutr. — 1999. — Vol. 70. — P. 811–816.

Villamor, D. J. Interpregnancy weight change and risk of adverse pregnancy outcomes: a populationbased study [Text] / D. J. Villamor, S. Cnattingius // Lancet. — 2006. — Vol. 368. — P. 1164–1170.

Fetal and placental size and risk of hypertension in adult life [Text] / D. J. Barker, A. R. Bull, C. Osmond [et al.] // BMJ. — 1990. — Vol. 301. — P. 259–262.

Effects of size at birth and childhood growth on the insulin resistance syndrome in elderly individuals [Text] / J. G. Eriksson, T. Forsen, J. Tuomilehto [et al.] // Diabetologia. — 2002. — Vol. 45. — P. 342–348.

Kershaw, E. E. Adipose tissue as an endocrine organ [Text] / E. E. Kershaw, J. S. Flier // J. Clin. Endocrinol. Metabol. — 2004. — Vol. 89, № 6. — P. 2548–2556.

Development of metabolic systems [Text] / K. L. Grove, B. E. Grayson, M. M. Glavas [et al.] // Physiol Behav. — 2005. — Vol. 86. — P. 646–660.

World Health Organization. Obesity: Preventing and managing the global epidemic [Text] // Technical report series no. 894. — Geneva: WHO, 2000. — 23 p.

Протоколи надання медичної допомоги дiтям за спецiальнiстю «Дитяча ендокринологiя» [Текст] — К., 2006. — С. 71.

Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects [Text] / L. Kennedy, D. C. Bittel, N. Kibiryeva [et al.] // Int. J. Obes. (Lond). — 2006. — Vol. 30, № 2. — P. 382–387.

Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism [Text] / O. Tschritter, A. Fritsche, C. Thamer [et al.] // Diabetes. — 2003. — Vol. 52. — P. 239–243.

Роль адипокинов и неэстерифицированных жирных кислот в развитии инсулинорезистентности [Текст] / Д. А. Танянский, Э. М. Фирова, Л. В. Шатилина [и др.] // Пробл. эндокринологии. — 2009. — Т. 55, № 3. — С. 13–17.

Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels [Text] / A. Böttner, J. Kratzsch, G. Müller [et al.] // J. Clin. Endocrinol. Metabol. — 2004. — Vol. 89, № 8. — P. 4053–4061.

Sexual dimorphism in plasma leptin concentration [Text] / M. F. Saad, S. Damani, R. L. Gingerich [et al.] // J. Clin. Endocrinol. Metabol. — 1997. — Vol. 82. — P. 579–584.

UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects [Text] / A. Widjaja, I. M. Stratton, R. Horn [et al.] // J. Clin. Endocrinol. Metabol. — 1997. — Vol. 82. — P. 654–657.

Плехова, Е. И. Содержание лептина в крови мальчиков с гипоталамическим синдромом пубертатного периода [Текст] / Е. И. Плехова, О. О. Хижняк, С. И. Турчина // Пробл. ендокрин. патологiї. — 2003. — № 4. — С. 29–31.

Haluzik, M. Adiponectin and its role in the obesityinduced insulin resistance and related complications [Text] / M. Haluzik, J. Parizkova, M. M. Haluzik // Physiol. Res. — 2004. — Vol. 53. — P. 123–129.

Ukkola, O. Adiponectin: a link between excess adiposity and associated comorbidities? [Text] / O. Ukkola, M. Santaniemi // J. Molec. Med. — 2002. — Vol. 80. — P. 696–702.

Роль лептина в формировании инсулинорезистентности у мальчиков-подростков [Текст] / О. О. Хижняк, Т. Н. Сулима, Е. И. Плехова [и др.] // Пробл. ендокрин. патологiї. — 2007. — № 4. — С. 17–25.

Birth weight and adult hypertension and obesity in women [Text] / G. C. Curhan, G. M. Chertow, W. C. Willett [et al.] // Circulation. — 1996. – Vol. 94. — P. 1310–1315.

Weight and Subsequent Risk of Type 2 Diabetes: A Meta-Analysis [Text] / T. Harder, E. Rodekamp, K. Schellong [et al.] // Amer. J. Epidemiol. — 2007. — Vol. 165, № 8 — P. 849–857.

Enhanced leptin sensitivity and attenuation of dietinduced obesity in mice with haploinsufficiency of Socs3 [Text] / J. K. Howard, B. J. Cave, L. J. Oksanen [et al.] // Nat. Med. — 2004. — Vol. 10. — P. 734–738.

Horvath, T. L. Developmental programming of the hypothalamus: a matter of fat [Text] / T. L. Horvath, J. C. Bruning // Nat. Med. — 2006. — Vol. 12. — P. 52–53.

Regulation of leptin synthesis and secretion before birth: implications for the early programming of adult obesity [Text] / I. C. McMillen, L. J. Edwards, J. Duffield [et al.] // Reproduction. — 2006. — Vol. 131. — P. 415–427.

Downloads

Published

2012-12-25

How to Cite

Khyzhnyak, O., Sulima, T. N., Cherevko, I. G., Manskaya, K. G., & Alekseeva, I. I. (2012). EFFECT OF PERINATAL FACTORS ON THE ADIPOCYTOKINE’S LEVEL IN OBESE PATIENTS. Problems of Endocrine Pathology, 42(4), 5-12. https://doi.org/10.21856/j-PEP.2012.4.01

Issue

Section

CLINICAL ENDOCRINOLOGY

Most read articles by the same author(s)

1 2 > >>